A new KIF5B-ERBB4 gene fusion in a lung adenocarcinoma patient

Related Experiment Video

Updated: Nov 10, 2025

Oncogenic Gene Fusion Detection Using Anchored Multiplex Polymerase Chain Reaction Followed by Next Generation Sequencing
09:49

Oncogenic Gene Fusion Detection Using Anchored Multiplex Polymerase Chain Reaction Followed by Next Generation Sequencing

Published on: July 5, 2019

9.8K

Edouard Guenzi1, Johan Pluvy2, Alice Guyard3

  • 1Dept of Genetics, University Hospital Bichat-Claude Bernard, Paris University, Paris, France.

ERJ Open Research
|April 5, 2021
PubMed

Abstract:

https://bit.ly/3nYmGQ9.

More Related Videos

A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds
13:34

A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds

Published on: April 6, 2016

10.4K
Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib
09:38

Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib

Published on: June 26, 2019

8.2K

Related Experiment Videos

Last Updated: Nov 10, 2025

Oncogenic Gene Fusion Detection Using Anchored Multiplex Polymerase Chain Reaction Followed by Next Generation Sequencing
09:49

Oncogenic Gene Fusion Detection Using Anchored Multiplex Polymerase Chain Reaction Followed by Next Generation Sequencing

Published on: July 5, 2019

9.8K
A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds
13:34

A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds

Published on: April 6, 2016

10.4K
Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib
09:38

Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib

Published on: June 26, 2019

8.2K

Related Concept Videos

The Retinoblastoma Gene01:20

The Retinoblastoma Gene

4.4K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.4K
The Ras Gene02:38

The Ras Gene

6.7K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
6.7K

Articles linked to this work by shared authors, journal, and citation graph.

Birt-Hogg-Dubé syndrome, prevalence of identified cases according to clinical indication in a cohort of 1,084 patients with genetic analysis.

Genetics in medicine : official journal of the American College of Medical Genetics·2026

Platelet GPVI drives fibrotic lung remodeling.

Blood advances·2026

Long-term real-world outcomes of nivolumab+ipilimumab treatment of unresectable pleural mesothelioma: update of Meso-Immune GFPC 04-2021 study.

Lung cancer (Amsterdam, Netherlands)·2026

Combined emphysema and cancer, from radiology to prognosis in patients treated by immunotherapy: An ancillary study of a prospective multicenter phase II IFCT-1802 SAVIMMUNE.

Respiratory medicine and research·2026

Diagnostic pitfalls and unmet needs in neuroendocrine neoplasms: The added value of collegial expert pathology review through the national TENpath network.

European journal of cancer (Oxford, England : 1990)·2026

External validation of the CAPAD score to predict the occurrence of clinically significant pneumothorax after CT-guided percutaneous transthoracic lung biopsy.

Respiratory medicine and research·2026

LUCIND: profiling respiratory comorbidity in paediatric neurological diseases.

ERJ open research·2026

Alcohol consumption and mortality in COPD: a population-based cohort study.

ERJ open research·2026

Cardiovascular outcomes in COPD, obstructive sleep apnoea and the overlap syndrome.

ERJ open research·2026

Comment on: A novel method to assess airway eosinophilia using sputum plugs.

ERJ open research·2026

Heart failure-related pleural effusion: determinants of pleural drainage and predictors of mortality in a cohort of 1372 patients.

ERJ open research·2026

Oligonucleotide correction of a rare CFTR intron 12 splicing variant from a cystic fibrosis patient.

ERJ open research·2026

Primary enteric-type adenocarcinoma of the renal parenchyma in a patient with bilateral renal malrotation: a case report and review of the literature.

Frontiers in oncology·2026

Beta-blocker use and survival in diffuse large B-cell lymphoma: a post hoc analysis of the RICOVER-60 trial.

Haematologica·2026

Vaginal Epithelial Pathology: A Review with Emphasis on Recent Developments.

Surgical pathology clinics·2026

Outcomes After Curative-intent Resection of Synchronous Primary Non-small cell lung cancer (NSCLC): Two is Worse than One.

The Journal of thoracic and cardiovascular surgery·2026

Breast metaplastic squamous cell carcinoma associated with a squamous-lined cyst: A potential distinct clinicopathologic subset.

Annals of diagnostic pathology·2026

RETRACTION: Clinicopathological and Prognostic Significance of ABCC3 in Human Glioma.

Journal of oncology·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us